Intelligient Automation
For A Smarter World
NovaWorks Digital builds innovative technology and helps small businesses reclaim hours, eliminate repetitive tasks, and focus on what actually drives results.
SynaptiCore: Autonomous Causal Discovery
NovaWorks is building the next generation of biomedical research tools. SynaptiCore moves beyond correlation by transforming fragmented biological data into computable causal mechanisms . Our platform autonomously generates, simulates, and verifies complex biological hypotheses, drastically cutting the time and cost associated with validating new disease targets. We don't just find what's broken—we find why and how to fix it.
Discovering the Non-Obvious Cure
SynaptiCore specializes in solving the multi-target challenge of complex disorders. Our Virtual Screening Engine runs millions of potential interventions, automatically escalating to combination therapies when single-target solutions are insufficient. In a verified test case, SynaptiCore autonomously discovered a synergistic drug cocktail that achieved 95.2% efficacy , demonstrating a crucial performance boost over the single best agent. NovaWorks is pioneering the move from single-drug therapy to optimized combination strategy.
Audit-Grade Scientific Authority
Credibility is the foundation of our work. Every finding generated by SynaptiCore is packaged into a fully auditable scientific brief, complete with explicit causal narratives, quantified simulation results, and a fixed execution seed for $100\%$ reproducibility . NovaWorks ensures that every proposed therapeutic pathway is not just effective in simulation, but traceable, consistent, and defensible for immediate clinical or translational development.
Our Vision: Redefining the Pace of Discovery
NovaWorks was founded on the conviction that the current paradigm of biomedical research is too slow, too fragmented, and too reliant on intuition. We envision a future where the critical initial steps of scientific discovery—hypothesis generation, causal reasoning, and intervention screening—are autonomous, accelerated, and auditable.
We are building the first generation of AI-native research platforms that function as complete "Machine Scientists," moving beyond simple data prediction to tackle complex biological causality.
Our Mission: Autonomous Solutions for Complex Disease
Our mission is to translate fragmented, textual scientific knowledge into actionable, computable intelligence. We aim to overcome the two primary bottlenecks in drug discovery for complex diseases (like neurodegeneration and oncology):
The Causal Bottleneck: Converting observed correlations into verified, mechanistic causal pathways.
The Intervention Bottleneck: Rapidly identifying synergistic, multi-target therapeutic combinations that are impossible to find using traditional, linear methods.
We are dedicated to providing researchers, biotech partners, and pharmaceutical companies with defensible, high-confidence targets, drastically shrinking the time between initial hypothesis and preclinical validation.